CHICAGO, Ill. -- By Lee Han-soo/Korea Biomedical correspondent – The Korean medical device industry is actively trying to advance into the U.S. market by establishing offshoots and hiring foreign executives and employees who know the American industry.Such a trend was apparent at the Radiological So
An Australian delegate comprised of bio-officials spanning research, academia, and industry, recently visited Korea to discuss partnerships with domestic biotech companies.At a meeting between the delegates and Korean biotech companies on Tuesday evening, Korea Biomedical Review sat down with two of
Mathematicians forecast that the number of new daily Covid-19 cases would decrease over the next two weeks. A team of mathematicians at the National Institute for Mathematical Sciences (NIMS) released a report on Thursday, saying that the size of Covid-19 infections is likely to shrink in Korea goin
A Korean research team has released a study result that confirmed the association between perivascular space dilation and cognitive decline in Alzheimer’s patients.The team analyzed the results of amyloid PET imaging and MRI brain imaging in Alzheimer's patients and published the results in the Octo
The “Accelerator-Boron Neutron Capture Therapy (A-BNCT)” has entered clinical trials as new anticancer therapy six months after it won approval.According to the minutes of the Central Pharmaceutical Review Committee made public recently, the developers – Dawon Medax and Gachon University Gil Medical
Yuhan Corp’s Leclaza (ingredient: lazertinib) demonstrated a 20.6 months of median progression-free survival (mPFS) as the first-line therapy for non-small cell lung cancer (NSCLC) treatment in a global phase 3 trial, the company said.Specifically, Leclaza’s mPFS in EGFR-mutated NSCLC patients was m
Roche has withdrawn Tecentriq’s indication for bladder cancer in the United States, but experts predict its effects on patients in clinical practice will not be significant.On Nov. 28, Genentech, an affiliate of Roche, said it would voluntarily withdraw Tecentriq’s U.S. indication for treating adult
Healthcare experts and industry leaders emphasized the importance of ESG (Environmental, social, governance) management in the pharmaceutical and biotech industry at a forum hosted by Korea Biomedical Review (KBR) in Seoul on Wednesday.KBR, a sister paper of Korean Doctors’ Weekly, launched the K-He
Takeda Pharmaceuticals Korea said Kynteles Prefilled Pen Inj. (Kynteles SC), an inflammatory bowel disease(IBD) treatment, started to be covered by health insurance on Thursday.Kynteles SC is subcutaneously injectable at home with the same efficacy as Kynteles intravenous injection (IV).Kynteles SC
Daewoong Pharmaceutical said on Thursday Envlo (ingredient: enavogliflozin), a new diabetes drug that inhibits sodium-glucose cotransporter 2 (SGLT-2), obtained domestic approval as monotherapy, metformin combination therapy, and metformin and gemigliptin combination therapy, to treat type-2 diabete
On Wednesday, Korea's new Covid-19 cases continued their downward trend week to week. Notably, according to health officials, the reproduction index, a gauge of future spreading trends, has fallen to approach 1, showing signs of stagnation or reduction.The country reported 67,415 new Covid-19 infect
CHICAGO, Ill. -- Coreline Soft was one of the Korean AI companies that attracted attention by addressing the unmet needs of radiologists during the Radiological Society of North America (RSNA) 2022 in Chicago, Ill., until Thursday.The company has regularly participated in RSNA since 2015, introducin
Korean doctors experience low self-satisfaction and burnout, as they cannot secure adequate treatment time due to low reimbursement, a report said. It called for raising medical fees to realistic levels and creating an environment that guarantees sufficient medical consultation.The Research Institut
A survey has found that seven out of 10 hypertension patients in Korea do not measure their blood pressure at home.It is important to know and practice the correct method to measure blood pressure at home because home measurement of blood pressure is useful for managing BP and improving patients’ dr
Middle-aged women with high diastolic blood pressure are 1.7 times likelier to develop breast cancer, so they need to be more careful with their usual BP control, a study said Wednesday.Hypertension and breast cancer are two of the most prevalent chronic diseases globally. Moreover, according to the
Celltrion said Wednesday that the company has secured a more stable basis of sales by winning patent rights for RemsimaSC, its autoimmune disease treatment, in an increasing number of countries.Celltrion has applied for patents for the formulation and the administration method of RemsimaSC in the U.
Lunsumio, Roche Korea’s lymphoma treatment, has become the first drug designated as the subject of the government’s Global Innovative products on Fast Track (GIFT).The Ministry of Food and Drug Safety said Tuesday that it had picked Lunsumio Inj. as the first product of the government’s GIGT system
No fewer than 92 percent of Korean doctors think pharmaceutical companies’ digital marketing activities enhanced in the non-contract era help them prescribe drugs, according to a survey.The largest number of respondents selected Daewoong Pharmaceutical as the drugmaker that conducts digital marketin
Helixmith said on Wednesday that it obtained a human cell management license from the Ministry of Food and Drug Safety (MFDS) to accelerate its contract development and manufacturing organization (CDMO) business portfolio in cell gene therapies.The human cell management license was newly established
CHICAGO, Ill. -- By Lee Han-soo/Korea Biomedical correspondent – GE Healthcare, which is planning a spinoff from GE on the first week of January next year, showed off over 40 medical imaging solutions to improve patient outcomes and increase healthcare efficiency at the Radiological Society of North